S&P 500
5.161,55 +33,76 (+0,66%) Nasdaq
16.271,32 +114,99 (+0,71%) NIKKEI 225
38.236,07 -38,03 (-0,10%) Dólar/Euro
1,0777 +0,0010 (+0,10%) Petróleo Brent
83,02 +0,06 (+0,07%) Bitcoin EUR
58.547,50 -1.258,39 (-2,10%)
Dr. Reddy's Laboratories Limited (RDY)
Dr. Reddy's Laboratories Limited
8-2-337, Road No. 3
Banjara Hills
Hyderabad 500034
India
91 40 4900 2900
https://www.drreddys.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 25.863
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD & Member of Management Council | 2,25M | N/A | 1960 |
| Mr. Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board & Member of the Management Council | 1,38M | N/A | 1967 |
| Mr. Erez Israeli M.B.A. | CEO & Member of the Management Council | N/A | N/A | 1968 |
| Mr. Parag Agarwal | CFO & Member of Management Council | N/A | N/A | 1967 |
| Mr. Deepak Sapra M.B.A. | CEO of API & Services & Member of Management Council | N/A | N/A | 1975 |
| Mr. Venkata Ramana Motupalli M.B.A. | CEO of Branded Markets - India & Emerging Countries and Member of Management Council | N/A | N/A | 1969 |
| Ms. Archana Bhaskar B.Sc., M.B.A. | EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council | N/A | N/A | 1967 |
| Mr. Sanjay Sharma B.Tech. | Executive VP, Global Head of Global Manufacturing & Member of Management Council | N/A | N/A | 1968 |
| Mr. Marc Kikuchi B.A., M.B.A. | CEO of North America Generics & Member of Management Council | N/A | N/A | 1969 |
| Mr. Patrick Aghanian B.A., M.B.A. | CEO of European Generics & Member of Management Council | N/A | N/A | 1965 |
Descripción
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Gobierno corporativo
El ISS Governance QualityScore de Dr. Reddy's Laboratories Limited, a día 1 de mayo de 2024, es 4. Las puntuaciones base son Auditoría: 6; Tablero: 4; Derechos de los accionistas: 1; Compensación: 7.
